Hormone therapy cluster
Hormone Therapy and Dementia: What Do We Actually Know?
This is the question where confident claims are most common and least justified — in both directions. What follows is a description of the state of the evidence, including its limits.
Medically Reviewed
Medically reviewed by Amarish Dave, DO
Board-Certified Neurologist
Last medically reviewed: September 10, 2026
Does hormone therapy prevent dementia?
No — and it should not be prescribed for that purpose. Professional guidance is consistent on this point: menopausal hormone therapy is indicated for menopausal symptoms in appropriately selected people, not for the prevention of cognitive decline or dementia.
Anyone marketing hormones as dementia prevention is going beyond the evidence. That includes framing it as "protecting your brain" without saying that the outcome data do not support the claim.
Does hormone therapy cause dementia?
That is not established either. Randomized data that raised concern came largely from women who started treatment years after menopause and at older ages, with particular formulations. Other studies have not found harm, and some observational work points the other way.
Holding both statements at once is uncomfortable but accurate: there is no reliable evidence that hormone therapy prevents dementia, and no reliable evidence that hormone therapy taken for symptom relief near the transition causes it.
Why do the studies disagree?
Because they studied different women, at different ages, with different drugs, for different lengths of time, using different outcomes. Those differences are large enough to produce genuinely conflicting results without any of the studies being wrong.
- Age at initiation and years since menopause differ substantially between studies
- Formulations differ — the estrogen and the progestogen both matter
- Route differs: oral versus transdermal are not pharmacologically equivalent
- Duration of treatment and duration of follow-up vary
- Observational studies are vulnerable to healthy-user and prescribing biases
- Dementia takes decades to develop; trials rarely run that long
What is the timing hypothesis, and is it proven?
It proposes that treatment started close to the menopausal transition may have different vascular and neural effects from treatment started a decade or more later. It is biologically plausible and consistent with some data, but it has not been proven by a trial designed to test long-term cognitive outcomes.
Treat it as an active research question. It is a reasonable part of a nuanced discussion with a clinician; it is not a basis for taking hormones in the expectation of preventing dementia.
What can actually be said about lowering dementia risk?
The strongest levers in midlife are vascular and lifestyle factors: blood pressure, glucose, lipids, physical activity, not smoking, moderating alcohol, treating hearing loss, treating depression, staying socially and cognitively engaged, and treating sleep disorders.
None of these guarantees anything for an individual — dementia risk is not fully modifiable. But this is where the evidence is strongest, and it is where midlife effort is best spent.
When should I talk to a clinician?
Reasonable questions for a clinician:
- What symptoms would hormone therapy be treating in my case?
- Given my age and years since menopause, how does that affect the balance?
- Which route and formulation would you choose for me, and why?
- What are my modifiable vascular risk factors right now?
- What would make you want to reassess this decision?
- Hormone therapy is not indicated for dementia prevention.
- It is also not established to cause dementia.
- Studies differ in age, timing, formulation and route.
- The timing hypothesis is unproven, not disproven.
- Vascular and lifestyle factors are the strongest known levers.
- Be wary of confident claims in either direction.
Educational assessment
The Menopause Brain Health Check organizes your symptoms and modifiable factors into patterns you can bring to an appointment. It is private, needs no account, and does not diagnose anything.
Questions
Common questions
Does hormone therapy prevent Alzheimer's disease?
No. Menopausal hormone therapy is not approved or recommended for preventing dementia or Alzheimer's disease. Observational studies and randomized trials have produced inconsistent results, and no professional guideline supports prescribing it for this purpose.
Does hormone therapy cause dementia?
That is not established either. Some data — notably from trials in women who began treatment well after menopause and at older ages — raised concern, while other data do not show harm and some observational work suggests the opposite. The honest summary is uncertainty, not a settled harm.
What is the timing hypothesis?
The idea that starting hormone therapy near the menopausal transition may have different effects from starting it many years later. It is a plausible hypothesis generated from observational and trial data, and it has not been confirmed by a trial designed to test long-term cognitive outcomes.
Share this page
Send this page to someone who may find it helpful.
Menopause changes more than hormones.
Follow the science of menopause, brain fog, sleep, migraine and long-term brain health with The MenoCortex Brief.
References & further reading
- 1.The Menopause Society — position statements and clinical guidance — The Menopause Society
- 2.Randomized trials and systematic reviews of hormone therapy and cognition — PubMed (NIH National Library of Medicine)
- 3.Cognitive health, memory changes and dementia information — National Institute on Aging (NIH)
- 4.Patient guidance on perimenopause, menopause and hormone therapy — American College of Obstetricians and Gynecologists